175 related articles for article (PubMed ID: 2162789)
61. Late onset adrenal hyperplasia in a group of Irish females who presented with hirsutism, irregular menses and/or cystic acne.
McLaughlin B; Barrett P; Finch T; Devlin JG
Clin Endocrinol (Oxf); 1990 Jan; 32(1):57-64. PubMed ID: 2139596
[TBL] [Abstract][Full Text] [Related]
62. Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency.
Milewicz A; Vecsei P; Korth-Schütz S; Haack D; Rösler A; Lichtwald K; Lewicka S; von Mittelstaedt G
J Steroid Biochem; 1984 Aug; 21(2):185-91. PubMed ID: 6090811
[TBL] [Abstract][Full Text] [Related]
63. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
64. Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.
Azziz R; Wells G; Zacur HA; Acton RT
J Clin Endocrinol Metab; 1991 Dec; 73(6):1327-31. PubMed ID: 1955515
[TBL] [Abstract][Full Text] [Related]
65. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
[TBL] [Abstract][Full Text] [Related]
66. Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland.
van Oers JW; Hinson JP; Binnekade R; Tilders FJ
Endocrinology; 1992 Jan; 130(1):282-8. PubMed ID: 1309333
[TBL] [Abstract][Full Text] [Related]
67. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation.
de Jong FH; Mallios C; Jansen C; Scheck PA; Lamberts SW
J Clin Endocrinol Metab; 1984 Dec; 59(6):1143-7. PubMed ID: 6092411
[TBL] [Abstract][Full Text] [Related]
68. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening.
Schulte HM; Chrousos GP; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
Horm Res; 1985; 21(2):69-74. PubMed ID: 2984099
[TBL] [Abstract][Full Text] [Related]
69. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
Newfield RS; Sarafoglou K; Fechner PY; Nokoff NJ; Auchus RJ; Vogiatzi MG; Jeha GS; Giri N; Roberts E; Sturgeon J; Chan JL; Farber RH
J Clin Endocrinol Metab; 2023 Oct; 108(11):2871-2878. PubMed ID: 37216921
[TBL] [Abstract][Full Text] [Related]
70. [Studies for clinical application of ovine corticotropin-releasing factor].
Kubo M
Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
[TBL] [Abstract][Full Text] [Related]
71. Adrenocortical 11 beta-hydroxylation defect in adult women with postmenarchial onset of symptoms.
Cathelineau G; Brerault JL; Fiet J; Julien R; Dreux C; Canivet J
J Clin Endocrinol Metab; 1980 Aug; 51(2):287-91. PubMed ID: 6249834
[TBL] [Abstract][Full Text] [Related]
72. Adrenal function under long-term raloxifene administration.
Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
[TBL] [Abstract][Full Text] [Related]
73. Results of the ACTH stimulation test in hirsute women.
Erel CT; Senturk LM; Oral E; Mutlu H; Colgar U; Seyisoglu H; Ertungealp E
J Reprod Med; 1999 Mar; 44(3):247-52. PubMed ID: 10202742
[TBL] [Abstract][Full Text] [Related]
74. [Hirsutism in Chilean women: importance of 21-hydroxylase congenital deficiency of late onset].
Gallardo E; Porcile A
Rev Med Chil; 1991 Feb; 119(2):147-51. PubMed ID: 1824156
[TBL] [Abstract][Full Text] [Related]
75. Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.
Schulte HM; Chrousos GP; Gold PW; Booth JD; Oldfield EH; Cutler GB; Loriaux DL
J Clin Invest; 1985 Jun; 75(6):1781-5. PubMed ID: 2989331
[TBL] [Abstract][Full Text] [Related]
76. Screening for non-classic 21-hydroxylase deficiency in an HLA-B14 positive population.
Motta P; Airaghi L; Catania A; Mangone I; Orsatti A; Tenconi L; Cantalamessa L; Zanussi C
Acta Endocrinol (Copenh); 1987 Oct; 116(2):211-5. PubMed ID: 2821719
[TBL] [Abstract][Full Text] [Related]
77. Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency.
Boscaro M; Betterle C; Sonino N; Volpato M; Paoletta A; Fallo F
J Clin Endocrinol Metab; 1994 Aug; 79(2):452-5. PubMed ID: 8045962
[TBL] [Abstract][Full Text] [Related]
78. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
79. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
[TBL] [Abstract][Full Text] [Related]
80. Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
Sarafoglou K; Barnes CN; Huang M; Imel EA; Madu IJ; Merke DP; Moriarty D; Nakhle S; Newfield RS; Vogiatzi MG; Auchus RJ
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4666-e4679. PubMed ID: 34146101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
